Leyland Streiff, from the advocacy group Protect Girls Sports in Maine, said in a news release that the proposal is "inclusive, fair and safe" and that the ballot initiative will let voters decide through "the most democratic process possible," the Maine Morning Star reported.
NHS England is "separately reviewing the evidence for the use of MAF in adults with gender dysphoria" with the aim of launching a consultation on its findings in late 2026. A separate section clarifies that its ban on new prescriptions will only apply to youth gender services, adding that the NHS will continue to prescribe hormones for adult patients in its gender identity clinics (GICs).
Republican-appointed judges reversed a ruling which blocked the ban, arguing with little evidence that gender-affirming care for trans adults was "dangerous," urging states not to fund what it spuriously described as "experimental procedures." It further claimed that trans people had become "disdainful of their sex" and claimed, again without evidence, that banning such provisions would "encourage citizens to appreciate their sex."
Administration health officials praised a statement released Tuesday by the American Society of Plastic Surgeons (ASPS) that advises against conducting "gender-related breast/chest, genital, and facial surgery" on people under the age of 19, even though such procedures are rarely conducted on minors. The ASPS based its statement on two recent reports from the U.K. and the U.S. that were widely criticized by transgender healthcare advocates as being biased.